ACC 2022 Conference Coverage
P

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment

By ACC 2022 Conference Coverage FEATURING Paul Heidenreich
By ACC 2022 Conference Coverage FEATURING Paul Heidenreich
20,816 views
April 21, 2022
8 Comments
Login to view comments. Click here to Login

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
16:55
Boston Scientific

Assessment of Primary Prevention Patients Receiving An ICD- Systemat…

Feat. C. Schuger
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
10:11
7th Annual Physiology of Pacing Symposium

LBBB Associated Cardiomyopathy: CRT-P or CRT-D?

Feat. S. Sundaram Ponnusamy
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
12:18
CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash
12:08
CCM® Therapy

HRS 2024: Why Cardiac Contractility Modulation?

Feat. J. Singh
12:44
CCM® Therapy

HRS 2024: The Impact of CCM® on My Practice

Feat. S. Jamal
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
15:56
Scripps Health

Ischemic Ventricular Tachycardia

Feat. D. Gibson
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
53:25
The Texas Heart Institute

Future Cardiology

Feat. J. Hill